MEDMIRA ESTABLISHES JOINT VENTURE IN CHINA

MedMira Inc. ("MedMira") (TSX Venture: MIR, NASDAQ:MMIRF), the global market leader in rapid flow-through diagnostic technology announced today that it has entered into a new strategic partnership with Tianhe Pharmaceutical Co., Ltd., established in 1952, one of the most successful pharmaceutical companies in China, and one of the country's Top 200 Companies in 2004. MedMira and Tianhe have formed a joint venture, which will open new market verticals in China including over-the-counter (OTC) sales for MedMira's current and future rapid diagnostic products.

Canada NewsWire (http://www.newswire.ca/en/releases/archive/August2005/09/c8400.html)